life-lines

image23
image24
image25

Bernard Munos Contributor

 Jan 14, 2019, 07:44am  Bernard Munos Contributor
 

2018 New Drugs Approvals: An All-Time Record, And A Watershed

Bernard Munos Contributor

 I study pharmaceutical innovation, what causes it and how to get more of it. Several of my papers, published in Nature and Science, have helped stimulate a rethinking of the industry business model. In 2012, the popular newsletter FiercePharma named me one of the 25 most influential people in biopharma. In 2013, I became a Senior Fellow at FasterCures (a center of the Milken Institute). Besides doing research, I spend a lot of time helping organizations – big, small, public, private, US and non-US – become better innovators. I learned my trade in the 30 years I spent in the industry at Eli Lilly. Before that, I trained as an animal scientist in France and earned additional degrees in business and economics from Stanford and UC-Davis. I serve on various boards and advisory bodies, including at NCATS, the Institute of Medicine, Glenmark Pharmaceuticals, think tanks and foundations. 

life-lines

CELG

image30

BMY

image31

LOXO

image32

PFE

image33

REGN

image34

NVS

image35

life-lines

GILD

image36

ABBV

image37

JNJ

image38

BMRN

image39

VRTX

image40

SGEN

image41

life-lines

EXEL

image42

AGN

image43

BGNE

image44

XON

SGMO

image45

NVO

image46